University of Nottingham
  • Print
  

 Why collaborate with the CHT?

 University of Nottingham adjacent to the Queens Medical Centre

Our track record

We have an extensive track record and experience of taking technologies from scientific discovery through to clinical adoption. This includes over 10 current University spin-out companies and other commercial ventures in healthcare and associated materials and manufacturing technologies, several technologies under license and mature technologies that have been on the market for many years.

Read more about the commercial success and validation of our spinouts

Our spinouts have had great commercial success and validation, for example:

  • £2m finance package from Mercia Technologies plc to regenerative medicine company Locate Bio;
  • £0.5m investment by Mercia Technologies plc into regenerative medicine company NuVision)
  • Buy-out of Monica Healthcare by GE Healthcare in 2017.
  • Three other medical spin-outs from the University of Nottingham  exited the portfolio or sold major shareholding in 2018  
 

Support over the complete pathway to clinical adoption

Uniquely placed within the NHS, CHEATA (Centre for Healthcare Equipment and Technology Adoption) can offer support and advice over the complete pathway from device development and regulatory compliance through to engagement with NICE. CHEATA helps overcome the obstacles to develop a market-ready product by supporting you to gather the evidence needed to translate your device from concept into clinical adoption. Find out more about CHEATA's services

Award-winning clinical-academic partnership

In 2018, the CHT won the NHS England Chief Scientific Officer's award for Developing partnerships to improve outcomes', recognising the success of the partnership. The University's scientific base is adjacent to and co-located with Nottingham University Hospitals NHS Trust - (NUH) ideal for clinical input and trials.

Read more about the the clinical research partnership

The Trust is one of the biggest and busiest in England, and is a highly active research organisation with ongoing clinical research in all Divisions and more than 400 active clinical research projects involving over 11,000 patients.

NUH has a longstanding and strong relationship with the University of Nottingham, exemplified by the £26m award for the NIHR Nottingham Biomedical Research Centre (BRC) and NIHR Nottingham Clinical Research Facilities (CRF).

Over 150 clinical academics along with clinical engineers and other clinicians are involved in research, giving rise to excellent clinical-academic collaboration in research projects. This leads to:

  • Research focussed on clinical priorities
  • Clinicians benefiting from the latest technologies, to improve patient care
 

Broad interdisciplinary capability

From over 100 academics working on healthcare technologies research, our breadth of scientific capability covers an all-round approach to device development: from human factors, to biomechanical evaluation, biomaterials, manufacturing and more, allowing us to bring together a bespoke team that is right for your device development.

 

Why Nottingham?

Nottingham sign

Situated in the heart of England, Nottingham is a fantastic location for medical device developers.

Find out about the MedTech hub of the UK and the support offered to local MedTech companies
  • Nottingham's Biocity (including Medicity) is a highly successful life science incubator space. Together with Nottingham-based Medilink East Midlands, and the East Midlands Academic Health Sciences Network, local companies benefit from a wealth of experience, support and access to funding.
  • Innovation space for start-ups is also available in the University of Nottingham Innovation Park, set within the award-winning Jubilee Campus.
  • Nottingham Trent University's Medical Technology Innovation Facility will support businesses in the fabrication and evaluation of medical devices with short term and flexible manufacturing facilities.
  • Cost of living and renting space is far cheaper than other big cities, yet is is less than 2 hours on the train from London, making it an easy day trip to and from the capital.
  • The Midlands is a hub for MedTech, with 16% of the total core Med Tech employment in the UK (the highest region outside the South East of England1). Almost 20% of all medical technology employees in the UK are based in the Midlands. The Midlands also holds the second highest number of companies formed since 2008 in this sector, demonstrating the sector's regional growth.
  • East Midlands is in the top 3 regions of the UK for Medical Technology service and supply chain companies (employment and turnover) with the most sites in the UK1. Nearly half of Medilink EM's members are based in Nottingham2, indicative of the city's particular strengths.

  • With two excellent Universities in Nottingham, there is a ready source of highly qualified graduates including PhDs. Regionally, Derby, Leicester and Loughborough, each with strong healthcare research and clinical involvement, are all within easy commuting distance and add to the local skill base.
  • The East Midlands is ethnically diverse, and stable population which supports representative recruitment in clinical trials.

1 Strength and Opportunities, 2017, 2Medilink Annual Report 2017